Log in or Sign up for Free to view tailored content for your specialty!
Schizophrenia News
‘Body maps’ show abnormal sensations of emotion in schizophrenia
Using a visual mapping task, researchers found that bodily sensations of emotions were abnormal in patients with schizophrenia, who reported less discrete and less clear bodily sensations across emotions compared with controls.
Age may modify the effects of long-acting injectable antipsychotics
Researchers found that long-acting injectable haloperidol decanoate was linked to lower rates of efficacy failure compared with long-acting injectable paliperidone palmitate, but only among younger individuals with schizophrenia.
Log in or Sign up for Free to view tailored content for your specialty!
Obsessive compulsive symptoms common in community youth
After assessing data from a large community sample of more than 7,000 youth, researchers found a high rate of obsessive-compulsive symptoms, particularly in females and after puberty.
Top psychiatry stories of 2018
As 2018 draws to a close, Healio Psychiatry has compiled a list of the top stories of the year for psychiatrists and other mental health professionals.
Higher schizophrenia risk scores tied to early-onset emotional problems
Development of emotional problems in early childhood was linked to higher risk for schizophrenia, study findings published in the American Journal of Psychiatry showed.
Remaining relapse-free key to long-term antipsychotic discontinuation
In a 10-year follow-up study of more than 100 patients with first-episode psychosis, researchers found that remaining relapse-free was the most significant predictor of successful long-term antipsychotic medication discontinuation.
Targeted cognitive training improves auditory, verbal outcomes in schizophrenia
Computerized targeted cognitive training improved auditory perception and verbal learning and reduced auditory hallucinations in patients with schizophrenia mandated to receive care at a rehabilitation center, study findings showed.
Novel psychotropic agent shows promise for schizophrenia
Sunovion Pharmaceuticals and PsychoGenics have announced positive results from a pivotal phase 2 study evaluating the efficacy and safety of SEP-363856, a novel psychotropic agent for schizophrenia, according to a press release.
Newborns with vitamin D deficiency at higher risk for later schizophrenia
Newborns with vitamin D deficiency had a 44% increased risk for schizophrenia in later life compared with those with normal vitamin D levels, according to study data reported in Scientific Reports.
Infections may increase risk for mental disorders, psychotropic use
Severe infections requiring hospitalization were linked to subsequent increased risk for hospitalization for any mental disorder and psychotropic medication use in Denmark, according to a nationwide cohort study published in JAMA Psychiatry.
-
Headline News
CDC confirms pediatric case of bird flu in California, first in US child
November 22, 20242 min read -
Headline News
GLP-1s may curb alcohol consumption in those with obesity
November 22, 20242 min read -
Headline News
‘You can have much more control’: The rise of in-house specialty pharmacies
November 25, 202411 min read
-
Headline News
CDC confirms pediatric case of bird flu in California, first in US child
November 22, 20242 min read -
Headline News
GLP-1s may curb alcohol consumption in those with obesity
November 22, 20242 min read -
Headline News
‘You can have much more control’: The rise of in-house specialty pharmacies
November 25, 202411 min read